Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Semiquantitative study of current coffee, caffeine, and ethanol intake in essential tremor cases and controls

Identifieur interne : 000A87 ( Istex/Curation ); précédent : 000A86; suivant : 000A88

Semiquantitative study of current coffee, caffeine, and ethanol intake in essential tremor cases and controls

Auteurs : Elan D. Louis [États-Unis] ; Eva C. Jurewicz [États-Unis] ; Lakeisha Applegate [États-Unis] ; Jose A. Luchsinger [États-Unis] ; Pam Factor-Litvak [États-Unis] ; Michael Parides [États-Unis]

Source :

RBID : ISTEX:A9392B00C08A0294490144968D52D0E6E9B4231D

English descriptors

Abstract

There are several reasons to study caffeine, coffee, and ethanol intake in essential tremor (ET) patients. ET patients also might modify their use of these beverages because of their effects on tremor. Intake of caffeine, coffee, and ethanol has not been quantified in a group of ET patients. Our objective is to use a semiquantitative food frequency questionnaire to compare current daily intake of coffee, caffeine, and ethanol in ET patients and controls. A total of 130 ET cases were patients at the Neurological Institute of New York, and 175 controls were ascertained by random digit dialing. Caffeine (in milligrams) and ethanol (in grams) intake were calculated from a semiquantitative food‐frequency questionnaire. Mean daily caffeine intake in patients was 138.4 versus 246.6 mg in controls; medians were 101.1 versus 175.5 mg (P < 0.001). Mean daily ethanol intake in patients was 8.2 versus 6.2 gm in controls; medians were 2.4 versus 1.9 gm (P = 0.89). Cases drank less coffee than controls, but drank similar amounts of tea, soft drinks, fruit juices, and milk. Daily caffeine intake was not correlated with tremor severity or duration. ET patients consumed less caffeine than did controls, which is likely to be a dietary modification in response to tremor. The observation that caffeine consumption was not correlated with tremor severity raises the additional possibility that lower caffeine consumption in ET patients may not exclusively be a response to tremor. A prospective study is needed to explore whether decreased caffeine consumption is a risk factor for ET. © 2004 Movement Disorder Society

Url:
DOI: 10.1002/mds.20035

Links toward previous steps (curation, corpus...)


Links to Exploration step

ISTEX:A9392B00C08A0294490144968D52D0E6E9B4231D

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Semiquantitative study of current coffee, caffeine, and ethanol intake in essential tremor cases and controls</title>
<author>
<name sortKey="Louis, Elan D" sort="Louis, Elan D" uniqKey="Louis E" first="Elan D." last="Louis">Elan D. Louis</name>
<affiliation wicri:level="1">
<mods:affiliation>The Gertrude H. Sergievsky Center, College of Physicians and Surgeons, Columbia University, New York, New York, USA</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>The Gertrude H. Sergievsky Center, College of Physicians and Surgeons, Columbia University, New York, New York</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<mods:affiliation>Department of Neurology College of Physicians and Surgeons, Columbia University, New York, New York, USA</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology College of Physicians and Surgeons, Columbia University, New York, New York</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<mods:affiliation>Taub Institute for Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University, New York, New York, USA</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Taub Institute for Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University, New York, New York</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Jurewicz, Eva C" sort="Jurewicz, Eva C" uniqKey="Jurewicz E" first="Eva C." last="Jurewicz">Eva C. Jurewicz</name>
<affiliation wicri:level="1">
<mods:affiliation>The Gertrude H. Sergievsky Center, College of Physicians and Surgeons, Columbia University, New York, New York, USA</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>The Gertrude H. Sergievsky Center, College of Physicians and Surgeons, Columbia University, New York, New York</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<mods:affiliation>Taub Institute for Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University, New York, New York, USA</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Taub Institute for Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University, New York, New York</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Applegate, Lakeisha" sort="Applegate, Lakeisha" uniqKey="Applegate L" first="Lakeisha" last="Applegate">Lakeisha Applegate</name>
<affiliation wicri:level="1">
<mods:affiliation>The Gertrude H. Sergievsky Center, College of Physicians and Surgeons, Columbia University, New York, New York, USA</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>The Gertrude H. Sergievsky Center, College of Physicians and Surgeons, Columbia University, New York, New York</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<mods:affiliation>Taub Institute for Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University, New York, New York, USA</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Taub Institute for Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University, New York, New York</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Luchsinger, Jose A" sort="Luchsinger, Jose A" uniqKey="Luchsinger J" first="Jose A." last="Luchsinger">Jose A. Luchsinger</name>
<affiliation wicri:level="1">
<mods:affiliation>Taub Institute for Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University, New York, New York, USA</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Taub Institute for Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University, New York, New York</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<mods:affiliation>Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, New York, USA</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, New York</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Factor Itvak, Pam" sort="Factor Itvak, Pam" uniqKey="Factor Itvak P" first="Pam" last="Factor-Litvak">Pam Factor-Litvak</name>
<affiliation wicri:level="1">
<mods:affiliation>Taub Institute for Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University, New York, New York, USA</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Taub Institute for Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University, New York, New York</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<mods:affiliation>Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, USA</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Parides, Michael" sort="Parides, Michael" uniqKey="Parides M" first="Michael" last="Parides">Michael Parides</name>
<affiliation wicri:level="1">
<mods:affiliation>Taub Institute for Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University, New York, New York, USA</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Taub Institute for Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University, New York, New York</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<mods:affiliation>Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, New York, USA</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, New York</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:A9392B00C08A0294490144968D52D0E6E9B4231D</idno>
<date when="2004" year="2004">2004</date>
<idno type="doi">10.1002/mds.20035</idno>
<idno type="url">https://api.istex.fr/document/A9392B00C08A0294490144968D52D0E6E9B4231D/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000A87</idno>
<idno type="wicri:Area/Istex/Curation">000A87</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Semiquantitative study of current coffee, caffeine, and ethanol intake in essential tremor cases and controls</title>
<author>
<name sortKey="Louis, Elan D" sort="Louis, Elan D" uniqKey="Louis E" first="Elan D." last="Louis">Elan D. Louis</name>
<affiliation wicri:level="1">
<mods:affiliation>The Gertrude H. Sergievsky Center, College of Physicians and Surgeons, Columbia University, New York, New York, USA</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>The Gertrude H. Sergievsky Center, College of Physicians and Surgeons, Columbia University, New York, New York</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<mods:affiliation>Department of Neurology College of Physicians and Surgeons, Columbia University, New York, New York, USA</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology College of Physicians and Surgeons, Columbia University, New York, New York</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<mods:affiliation>Taub Institute for Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University, New York, New York, USA</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Taub Institute for Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University, New York, New York</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Jurewicz, Eva C" sort="Jurewicz, Eva C" uniqKey="Jurewicz E" first="Eva C." last="Jurewicz">Eva C. Jurewicz</name>
<affiliation wicri:level="1">
<mods:affiliation>The Gertrude H. Sergievsky Center, College of Physicians and Surgeons, Columbia University, New York, New York, USA</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>The Gertrude H. Sergievsky Center, College of Physicians and Surgeons, Columbia University, New York, New York</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<mods:affiliation>Taub Institute for Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University, New York, New York, USA</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Taub Institute for Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University, New York, New York</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Applegate, Lakeisha" sort="Applegate, Lakeisha" uniqKey="Applegate L" first="Lakeisha" last="Applegate">Lakeisha Applegate</name>
<affiliation wicri:level="1">
<mods:affiliation>The Gertrude H. Sergievsky Center, College of Physicians and Surgeons, Columbia University, New York, New York, USA</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>The Gertrude H. Sergievsky Center, College of Physicians and Surgeons, Columbia University, New York, New York</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<mods:affiliation>Taub Institute for Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University, New York, New York, USA</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Taub Institute for Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University, New York, New York</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Luchsinger, Jose A" sort="Luchsinger, Jose A" uniqKey="Luchsinger J" first="Jose A." last="Luchsinger">Jose A. Luchsinger</name>
<affiliation wicri:level="1">
<mods:affiliation>Taub Institute for Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University, New York, New York, USA</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Taub Institute for Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University, New York, New York</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<mods:affiliation>Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, New York, USA</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, New York</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Factor Itvak, Pam" sort="Factor Itvak, Pam" uniqKey="Factor Itvak P" first="Pam" last="Factor-Litvak">Pam Factor-Litvak</name>
<affiliation wicri:level="1">
<mods:affiliation>Taub Institute for Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University, New York, New York, USA</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Taub Institute for Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University, New York, New York</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<mods:affiliation>Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, USA</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Parides, Michael" sort="Parides, Michael" uniqKey="Parides M" first="Michael" last="Parides">Michael Parides</name>
<affiliation wicri:level="1">
<mods:affiliation>Taub Institute for Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University, New York, New York, USA</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Taub Institute for Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University, New York, New York</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<mods:affiliation>Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, New York, USA</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, New York</wicri:regionArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2004-05">2004-05</date>
<biblScope unit="vol">19</biblScope>
<biblScope unit="issue">5</biblScope>
<biblScope unit="page" from="499">499</biblScope>
<biblScope unit="page" to="504">504</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">A9392B00C08A0294490144968D52D0E6E9B4231D</idno>
<idno type="DOI">10.1002/mds.20035</idno>
<idno type="ArticleID">MDS20035</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>alcohol</term>
<term>caffeine</term>
<term>coffee</term>
<term>epidemiology</term>
<term>essential tremor</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="fr">There are several reasons to study caffeine, coffee, and ethanol intake in essential tremor (ET) patients. ET patients also might modify their use of these beverages because of their effects on tremor. Intake of caffeine, coffee, and ethanol has not been quantified in a group of ET patients. Our objective is to use a semiquantitative food frequency questionnaire to compare current daily intake of coffee, caffeine, and ethanol in ET patients and controls. A total of 130 ET cases were patients at the Neurological Institute of New York, and 175 controls were ascertained by random digit dialing. Caffeine (in milligrams) and ethanol (in grams) intake were calculated from a semiquantitative food‐frequency questionnaire. Mean daily caffeine intake in patients was 138.4 versus 246.6 mg in controls; medians were 101.1 versus 175.5 mg (P < 0.001). Mean daily ethanol intake in patients was 8.2 versus 6.2 gm in controls; medians were 2.4 versus 1.9 gm (P = 0.89). Cases drank less coffee than controls, but drank similar amounts of tea, soft drinks, fruit juices, and milk. Daily caffeine intake was not correlated with tremor severity or duration. ET patients consumed less caffeine than did controls, which is likely to be a dietary modification in response to tremor. The observation that caffeine consumption was not correlated with tremor severity raises the additional possibility that lower caffeine consumption in ET patients may not exclusively be a response to tremor. A prospective study is needed to explore whether decreased caffeine consumption is a risk factor for ET. © 2004 Movement Disorder Society</div>
</front>
</TEI>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000A87 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 000A87 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Istex
   |étape=   Curation
   |type=    RBID
   |clé=     ISTEX:A9392B00C08A0294490144968D52D0E6E9B4231D
   |texte=   Semiquantitative study of current coffee, caffeine, and ethanol intake in essential tremor cases and controls
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024